We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Myriad Suing Two Competitors; Keeps DNA Patent Debate Alive
Myriad Suing Two Competitors; Keeps DNA Patent Debate Alive
July 12, 2013
Myriad Genetics has filed suit against Ambry Genetics and Gene by Gene, two of its competitors that began marketing less-expensive versions of its diagnostic breast cancer test the same day a unanimous Supreme Court ruled against patenting isolated human DNA.